Remdesivir 

Remdesivir  is causing "rapid recoveries in fever and respiratory symptoms, with nearly ALL patients discharged in less than a week" 

"The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies," 

The results came from the University of Chicago Medicine, which is participating in two Gilead clinical trials involving 2,400 severe cases at 152 sites and 1,600 moderate cases at 169 sites, 

https://www.usatoday.com/story/money/2020/04/17/remdesivir-coronavirus-drug-gilead-sciences-covid-19-treatment/5150793002/